Get started
Work

Abstract RF01-07: The efficacy and safety of tinengotinib in patients with advanced or metastatic HR+/HER2- breast cancer or TNBC

Year: 2024
Type: conference-abstract
DOI: 10.1158/1538-7445.sabcs23-rf01-07
Authors: Piha-Paul Sarina, Binghe Xu, Ying Fan, Yuan Yuan, Sayeh Lavasani, Joanne Mortimer, Sanjay Goel, Apostolia Tsimberidou, Nuhad Ibrahim, Sausan Abouharb, Carlos Barcenas, Adaeze lheme, Daniel Karp, Jordi Rodon Ahnert, Ecaterina Dumbrava, Jean Fan, Peng Peng, Caixia Sun, Hui Wang, Katie Hennessy, Ximei Fu, Ruolan Xu, Shumao Ni, Frank Wu, Funda Meric-Bernstam
Institutions: The University of Texas MD Anderson Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Cedars-Sinai Medical Center, University of California, Irvine, City Of Hope National Medical Center, City of Hope, Rutgers Cancer Institute
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4396599072
Cites:
Cited by:
Related to: 10